Skip to main content

Global Emerging Sleep Apnea Devices and Platforms Market to Reach $ 13,179.6 Million by 2030

 According to a new market intelligence report by BIS Research titled “Global Emerging Sleep Apnea Devices and Platforms Market- Analysis and Forecast, 2021-2030,” The global emerging sleep apnea devices and platforms market is projected to reach up to $ 13,179.6 million by 2030, witnessing a compound annual growth rate (CAGR) of 9.94% during the forecast period 2021-2030. The market is anticipated to witness a significant growth of 25.25% in 2020 due to the COVID-19 pandemic. However, due to the overproduction of PAP devices and delayed resumption of the clinical services, the market is anticipated to witness a significant decline of 17.12% in 2021. From 2022, normalization within the global market is expected.

BIS Research Report -  https://bisresearch.com/industry-report/sleep-apnea-device-market.html

DNA damage response drugs have emerged as one of the most promising cancer therapies in the field of oncology. DNA damage response drugs are primarily utilized to kill cancerous cells while minimizing the impact on non-cancerous cells. These novel anti-cancer drugs have immense potential in terms of offering a selective and efficient tolerated treatment approach for improving cancer survival rates. The development of DNA damage response drugs potentially harnesses various proteins involved in the DNA damage response pathway such as Poly (ADP-ribose) polymerase (PARP), WEE1, Aurora B, ATM kinase, and ATR kinase. Pharmaceutical companies, typically operating in the field of cancer therapeutics, harness this pathway and associated proteins for therapeutic benefits, thereby offering active and maintenance treatment, further increasing progression-free survival (PFS) of patients suffering from advanced cancer.

During the forecast period 2021-2030, the global emerging sleep apnea devices and platforms market is expected to be impacted by various growth-promoting and inhibiting factors. For instance, the growing awareness regarding the ill effects of untreated sleep apnea, rising demand for portable sleep apnea devices, and technological advancements in sleep screening and monitoring would be the propellers for the market growth. Moreover, the increasing usage of oral appliances is anticipated to be moderately impacting the market due to a lack of reimbursement of oral appliances and the high cost of dental treatment.

Request for a Sample: https://bisresearch.com/requestsample?id=820&type=download

However, the high upfront cost of the sleep apnea devices and the unequal global reimbursement landscape would restrain the growth of the market considerably. The following figure represents the impact analysis for various market drivers and restraints for the global emerging sleep apnea devices and platforms market.

The majorly employed strategy for entering the market was the launch of novel products. Various emerging companies, such as Inspire Medical Systems, Inc., LivaNova PLC, Nyoxah S.A., Signifier Medical Technologies Limited, and Alaxo GmbH, Beddit, Oura, Dreem, PMD Device Solutions Limited, and EMFIT launched their products between 2016-2020.

 

The answers to the following key questions can be derived from this report:

·         How has the COVID-19 pandemic impacted the global emerging sleep apnea devices and platforms market?

·         How can the usage of continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo-ventilators (ASV) during the COVID-19 pandemic, impact the adoption of clinical ventilators?

·         How can the market cater to global healthcare system requirements, such as remote patient monitoring, constant collection of clinical data, and clinical data management and its analysis?

·         What is the global regulatory landscape of the global emerging sleep apnea devices and platforms market? How have the regulations altered due to the COVID-19 pandemic?

·         What has been the patent landscape for the market during 2017-2020? How has the COVID-19 pandemic impacted the patent scenario?

·         What are the major companies operating in the market and their respective market share?

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...
Post a Comment
Read more